MARKET

CNSP

CNSP

CNS PHARMACEUTICALS, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.660
+0.260
+10.83%
After Hours: 2.690 +0.03 +1.13% 18:55 05/29 EDT
OPEN
2.310
PREV CLOSE
2.400
HIGH
2.780
LOW
2.310
VOLUME
89.25K
TURNOVER
--
52 WEEK HIGH
5.69
52 WEEK LOW
1.258
MARKET CAP
43.76M
P/E (TTM)
-7.0277
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CNSP stock price target is 11.00 with a high estimate of 11.00 and a low estimate of 11.00.

EPS

CNSP News

More
65 Biggest Movers From Yesterday
Gainers ARCA biopharma, Inc. (NASDAQ: ABIO) shares climbed 386.3% to close at $19.21 on Thursday after the company announced the development program for its AB201 treatment of coronavirus associated with coagulopathy.
Benzinga · 1d ago
48 Stocks Moving In Thursday's Mid-Day Session
Gainers ARCA biopharma, Inc. (NASDAQ: ABIO) shares jumped 207.6% to $12.15 after the company announced the development program for its AB201 treatment of coronavirus associated with coagulopathy.
Benzinga · 2d ago
CNS Pharma Reports Sponsored Research Deal With University Of Texas MD Anderson Cancer Center For Potential Cancer Treatment Technologies
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and
Benzinga · 2d ago
CNS Pharmaceuticals Announces Sponsored Research Agreement with MD Anderson for Potential Cancer Treatment Technologies
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, announces it has entered into a spons
PR Newswire · 2d ago
CNS Announces Common Stock Will Resume Trading on the NASDAQ on May 28, 2020
CNS Pharmaceuticals, Inc., (Nasdaq: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that it has received
PR Newswire · 3d ago
Nasdaq Scheduled Resumption in CNS Pharmaceuticals Inc.
GlobeNewswire · 3d ago
CNS Pharmaceuticals Highlights Moleculin's Pre-IND Meeting For WP1122; CNS Previously Entered Agreement For Development Of Drugs Including WP1122
HOUSTON, May 27, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc., (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for
Benzinga · 3d ago
CNS Provides Update on Development Agreement for WP1122
CNS Pharmaceuticals, Inc., (Nasdaq: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today provided an update on the deve
PR Newswire · 3d ago

Industry

Biotechnology & Medical Research
+1.44%
Pharmaceuticals & Medical Research
+1.29%

Hot Stocks

Symbol
Price
%Change

About CNSP

CNS Pharmaceuticals Inc. is a preclinical stage pharmaceutical company. The Company is focused on developing anticancer drug candidates for the treatment of brain and central nervous system tumors. The Company is focused on developing its lead drug candidate, Berubicin for the treatment of glioblastoma. Glioblastoma are tumors that arise from astrocytes, which are star-shaped cells making up the supportive tissue of the brain. Berubicin is an anthracycline, a class of drugs that are among the chemotherapy drugs, which intercalates into Deoxyribonucleic acid (DNA) and interrupts topoisomerase II activity. It results in the inhibition of DNA replication and repair, and Ribonucleic acid (RNA) and protein synthesis.
More

Webull offers kinds of CNS Pharmaceuticals Inc stock information, including NASDAQ:CNSP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CNSP stock news, and many more online research tools to help you make informed decisions.